Press release
A Breakthrough in Healing: Ketamine Therapy Restores Hope for Depression, Anxiety and PTSD Transforming Mental Health
Saratoga, California - In a time when rates of depression, anxiety, and trauma-related disorders are at an all-time high, a groundbreaking treatment is offering renewed hope to those who have struggled with traditional therapies. The Couch is proud to announce the expansion of its advanced Ketamine-Assisted Therapy Program, an evidence-based, rapid-acting treatment that is changing the landscape of mental health care.
Unlike conventional antidepressants, which can take weeks to months to show results, ketamine therapy often provides relief within hours or days. Administered in a calm, medically supervised environment, ketamine works by enhancing neuroplasticity - helping the brain form new, healthy connections that support healing and emotional resilience.
"Many of our clients come to us after years of trying traditional treatments with little improvement," said Stefanie Smith, Licensed Marriage and Family Therapist, Clinical Director Founder at The Couch. "Ketamine therapy offers a new path forward - one that restores hope, helps patients reconnect with themselves, and reignites their capacity for joy."
Research from leading institutions such as Yale, Stanford, and the National Institutes of Health continues to validate ketamine's transformative potential for conditions including major depression, PTSD, anxiety disorders, and chronic pain. When combined with psychotherapy, patients often experience deeper emotional insight and sustained progress beyond symptom reduction.
What Sets The Couch Apart At The Couch, ketamine therapy is delivered by a compassionate team of licensed clinicians who specialize in integrative mental health. Each treatment plan is individualized and includes guided support before, during, and after each session to ensure lasting change.
"Ketamine therapy isn't just about symptom relief - it's about helping people rediscover meaning, purpose, and possibility," added Stefanie Smith. "It's one of the most exciting advancements in mental health in decades."
Now Accepting New Clients In California
To learn more about ketamine-assisted therapy or to schedule a confidential consultation via telehealth video conference, visit https://thetherapycouch.net or call 1-408-214-8349.
Media Contact
Company Name: The Couch
Contact Person: Media Manager
Email: Send Email [http://www.universalpressrelease.com/?pr=a-breakthrough-in-healing-ketamine-therapy-restores-hope-for-depression-anxiety-and-ptsd-transforming-mental-health]
Phone: +1-408-214-8349
Address:236 N Santa Cruz Ave Suite 203
City: Los Gatos
State: California
Country: United States
Website: https://thetherapycouch.net
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release A Breakthrough in Healing: Ketamine Therapy Restores Hope for Depression, Anxiety and PTSD Transforming Mental Health here
News-ID: 4251696 • Views: …
More Releases from Getnews
Bloomly Kids Introduces New Tools to Support School and Daycare Enrollment Growt …
Image: https://www.globalnewslines.com/uploads/2025/12/1765760392.jpg
The early education marketing solutions provider helps schools and daycares attract more families and streamline operations.
Los Angeles, CA - Bloomly Kids, a leading provider of early education marketing solutions [https://www.bloomlykids.com/], today announced new initiatives designed to help schools and daycares across the U.S. boost enrollment and improve family engagement. Since 2018, the company has supported thousands of institutions, from small daycare centers to large preschools, in achieving measurable growth…
Funeral Director Ronald Moy Death Calls for Stronger Community Support Around Gr …
Image: https://www.globalnewslines.com/uploads/2025/12/1765836081.jpg
Ronald Moy, Escondido California
Escondido leader urges residents to take simple steps to support neighbours coping with loss
Following his recent in-depth interview, long-time funeral director Ronald Moy is calling for greater community involvement in grief awareness and support. With more than twenty years of experience guiding families through bereavement, Moy says the public often underestimates the long-term effects of loss - and the role everyday people can play in easing…
Gage Nelson Handyman Service Brings Reliable Home Repairs to Bradenton's Booming …
Image: https://www.globalnewslines.com/uploads/2025/12/1765834473.jpg
Bradenton, FL - December 15, 2025 - Gage Nelson Handyman Service of Bradenton [https://gagenelsonhandyman.com/]continues to support the area's booming real estate market by providing dependable, high-quality handyman services for homeowners, investors, and property managers throughout the region. With Bradenton ranked among the fastest-growing cities on Florida's Gulf Coast, the demand for skilled, trustworthy home repair professionals has never been higher. Gage Nelson and his team are stepping in to…
Brook Targets Brazil's Obesity and Peptide Market Expected to Reach USD 2 Billio …
Image: https://www.globalnewslines.com/uploads/2025/12/59bd0361b997195b755a1ec6b88d8535.jpg
Anapolis, Brazil - Brazilian pharmaceutical company Brook S/A is positioning itself as a key player in the peptide supply chain as Brazil's obesity and metabolic treatment market expands rapidly, driven by growing medical adoption of therapies such as tirzepatide and, in the future, retatrutide.
According to industry estimates, Brazil's obesity and metabolic treatment market - including reference drugs, compounded therapies and the broader peptide active pharmaceutical ingredient (API) supply chain…
More Releases for Ketamine
Ketamine Treatment Market Growth by Top Company, Product Price, Profit
The Ketamine Treatment Market was valued at USD 4.33 Bn in 2024, and total global Ketamine Treatment Market revenue is expected to grow at a CAGR of 11.7% & reaching nearly USD 10.49 Bn from 2025-2032
Ketamine Treatment Market Overview:
The Ketamine Treatment Market is witnessing strong growth as ketamine emerges as a transformative therapy for mental health disorders, including depression, anxiety, and PTSD. Increasing acceptance of ketamine-based treatments in clinical settings,…
Ketamine-Assisted Therapy in Bethesda MD: A Compassionate Alternative to Traditi …
Ketamine-assisted therapy at Calliope Health Ketamine in Bethesda MD offers a caring and therapeutic alternative for those who haven't found relief through traditional treatment. By combining ketamine infusion with emotional support and psychotherapy, individuals gain a safe space to process feelings, reconnect with themselves, and move toward meaningful healing-not just symptom management.
There comes a point when someone who has been trying their best-showing up for therapy, taking their prescribed medications,…
Breakthroughs in Mental Health: Calliope Health Ketamine Expands Access to Ketam …
In recent years, the landscape of mental health treatment has seen remarkable advancements, with innovative therapies offering new hope to those battling conditions like depression, anxiety, and PTSD. Among these breakthroughs, ketamine therapy has emerged as a powerful option, providing rapid relief for individuals who have not responded to traditional treatments. Calliope Health Ketamine is at the forefront of this movement, expanding access to ketamine therapy in Maryland, where it…
Ketamine treatment Market 2023 Driving Factors Forecast Research 2029
Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market's growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine's ability to bring relief to TRD sufferers has resulted in its increased use…
Ketamine treatment Market 2023 Driving Factors Forecast Research 2029
Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market's growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine's ability to bring relief to TRD sufferers has resulted in its increased use…
Ketamine Treatment Market to Witness Astonishing Growth by 2029
The global ketamine treatment market is anticipated to grow at a CAGR of 43.7% during the forecast period (2023-2030). Ketamine has been widely used in the treatment of various conditions, including major depressive disorder, treatment-resistant depression (TRD), bipolar depression, post-traumatic stress disorder, anxiety disorders, chronic pain management, and migraine or headache management. Ketamine is also been used in the form of infusion therapy and nasal spray, and has been found…
